- Home
- GPMT vs NKTR Comparison
GPMT vs NKTR Comparison
Compare GPMT & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GPMT | NKTR |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.8M | 1.1B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | GPMT | NKTR |
|---|---|---|
| Price | $2.67 | $54.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $3.13 | ★ $106.33 |
| AVG Volume (30 Days) | 138.9K | ★ 603.1K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 7.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $62,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.61 | $6.48 |
| 52 Week High | $3.49 | $66.92 |
Technical Indicators
Market Signals| Indicator | GPMT | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 43.80 | 46.29 |
| Support Level | $2.73 | $50.49 |
| Resistance Level | $2.82 | $59.23 |
| Average True Range (ATR) | 0.08 | 4.11 |
| MACD | -0.00 | -0.67 |
| Stochastic Oscillator | 40.00 | 27.00 |
Price Performance
Historical ComparisonAbout GPMT Granite Point Mortgage Trust Inc.
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.